Prof. Waljit S. Dhillo
Endocrinology and Metabolism at Imperial College
Biography & Research Background
Waljit S. Dhillo, BSc MBBS PhD, is Professor of Endocrinology and Metabolism at Imperial College London, Department of Investigative Medicine. Prof. Dhillo conducted the first-in-human kisspeptin administration studies in men (2005) and women (2007), establishing kisspeptin as a potent stimulator of the HPG axis. His research program has characterized the therapeutic potential of kisspeptin across IVF treatment (Phase 2 trials demonstrating safe oocyte maturation without OHSS), hypothalamic amenorrhea, psychosexual disorders, and neuroimaging studies of sexual and emotional brain processing. He led the first human intranasal kisspeptin trial (2025), validating non-invasive delivery. Waljit S. Dhillo is being referenced as one of the leading scientists involved in the research and development of Kisspeptin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Prof. Waljit S. Dhillo is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Prof. Waljit S. Dhillo is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.